Close Menu

    Subscribe to Updates

    Get the latest information from JBUON.

    What's Hot

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025
    Facebook X (Twitter) Instagram
    JBUONJBUON
    • How to Submit
    • Author Guidelines
    Facebook X (Twitter) Instagram
    SUBMIT
    • Home
    • Browse Issues
      • In Press
      • Current Issue
      • Archives
    • About Journal
      • Journal Information
      • Editorial Board
      • Bibliographic Listings
      • Editorial Policy
      • Ethics and Malpractice Statement
    • For Authors
      • How To Submit
      • Submit Article
      • Downloads
    • Contact
    JBUONJBUON
    Home»Volume 18, Issue 4 (October-December 2013)

    Volume 18, Issue 4 (October-December 2013)

    REVIEW ARTICLES

    Current role of immunotherapy for the treatment of prostate cancer
    O. Porfyris, P. Kalomoiris; pp 809-817 (Abstract, PDF)

    Sexual dysfunction in cancer patients: a review
    B. Cakar, B. Karaca, R. Uslu; pp 818-823 (Abstract, PDF)

    BREAST CANCER

    Impact of the obesity on lymph node status in operable breast cancer patients
    O. Keskin, S. Aksoy, T. Babacan, F. Sarici, N. Kertmen, M. Solak, F.P. Turkoz, Z. Arik, E. Esin, I. Petekkaya,
    K. Altundag; pp 824-830 (Abstract, PDF)

    Capecitabine/cisplatin doublet in anthracycline and taxane pretreated and HER-2 negative metastatic
    breast carcinoma patients
    N. Ozdemir, S. Aksoy, M. A. N. Sendur, M. B. Akinci, O. Yazici, B. Budakoglu, H. Abali, B. Oksuzoglu,
    N. Zengin; pp 831-837 (Abstract, PDF)

    Comparative efficacy study of 5-year letrozole or anastrozole in postmenopausal hormone receptor-
    positive early breast cancer
    M. A. N. Sendur, S. Aksoy, N. Zengin, K. Altundag; pp 838-844 (Abstract, PDF)

    The relationship of insulin resistance and metabolic syndrome with known breast cancer prognostic
    factors in postmenopausal breast cancer patients
    A. Can, A. Alacacioglu, Y. Kucukzeybek, C. Erten, S. Cokmert, L. Demir, A. Dirican, I. Vedat Bayoglu,
    M.Akyol, F. Aslan, M. Oktay Tarhan; pp 845-850 (Abstract, PDF)

    Age related influence of triple receptor status on metastatic breast cancer post relapse survival
    N. Todorovic-Rakovic, Z. Neskovic-Konstantinovic; pp 851-858 (Abstract, PDF)

    Prognostic factors for longer disease free survival and overall survival after surgical resection of
    isolated liver metastasis from breast cancer
    M. Zegarac, S. Nikolic, D. Gavrilovic, M. Jevric, D. Kolarevic, Z. Nikolic-Tomasevic, M.Kocic, I. Djurisic, Z. Inic,
    V. Ilic , N. Santrac; pp 859-865 (Abstract, PDF)

    The prognostic role of interleukin-8 (IL-8) and matrix metalloproteinases -2 and -9 in lymph
    node-negative untreated breast cancer patients
    J. Milovanovic, N. Todorovic-Rakovic, Z. Abu Rabi; pp 866-873 (Abstract, PDF)

    The effects of anastrozole on the proliferation of FM3A cells
    M. Topcul, I. Cetin, M. Ozlem Kolusayin Ozar; pp 874-878 (Abstract, PDF)

    Prognostic value of EZH2, paxillin expression and DNA ploidy of breast adenocarcinoma: Correlation
    to pathologic predictors
    D. Panousis, G. Xepapadakis, E. Lagoudianakis, G. Karavitis, N. Salemis, N. Koronakis, E. Patsouris, D.
    Koronarchis, D. Grosomanidis, G. Chryssikos, P. Ntasiou, V. Kyriakidou, A. M. Athanassiadou, P.Athanassiadou; pp 879-885 (Abstract, PDF)

    Characterization of immunohistochemical markers in triple negative breast carcinomas
    E. Atik, M. Guray, T. Ozgur, T. Canda; pp 886-890 (Abstract, PDF)

    Promoter methylation assay of SASH1 gene in breast cancer
    Lin Sheyu, Liu Hui, Zhang Junyu, Xu Jiawei, Wang Honglian, Sang Qing, Zhang Hengwei, Guo Xuhui,
    Xing Qinghe, He Lin; pp 891-898 (Abstract, PDF)

    LUNG CANCER

    Third-line therapy in advanced non-small cell lung cancer
    Zhen Ying Geng, Shun Chang Jiao, Shi Cui Liu, Ying Li, Zhe Feng Liu, Guo Qing Zhang, Li Jie Wang, Feng Qu; pp 899-907 (Abstract, PDF)

    Lentivirus-mediated shRNA interference targeting cyclooxygenase2 inhibits growth of human non-small
    cell lung cancer
    Tianrong Li, Jie Lu, Yunhua Zhong; pp 908-914 (Abstract, PDF)

    Stress protein Hsp27 expression predicts the outcome in operated small cell lung carcinoma and large cell
    neuroendocrine carcinoma patient
    D. M. Marinova, Y. G. Slavova, N. Trifonova, D. Kostadinov, V. Maksimov, D. Petrov; pp 915-920 (Abstract, PDF)

    Clinical and prognostic importance of XIAP and USP8 in advanced stages of non-small cell lung cancer
    M. Baykara, M. Yaman, S. Buyukberber, G. Tufan, U. Demirci, M. Benekli, U. Coskun, A. Ozet, E. Umit Bagriacik; pp 921-927 (Abstract, PDF)

    Differential diagnosis of pulmonary lesions by parametric imaging in 18F-FDG PET/CT dynamic multi-bed
    scanning
    Qiang Wang, Rong-fu Wang, Jianhua-Zhang, Yun Zhou; pp 928-934 (Abstract, PDF)

    Diagnostic value of PET/CT in differentiating benign from malignant solitary pulmonary nodules
    A. Dalli, H. Selimoglu Sen, M. Coskunsel, H. Komek, O. Abakay, C. Sergi, A. Cetin Tanrikulu; pp 935-941 (Abstract, PDF)

    UROLOGIC CANCERS

    Evaluation of efficacy and toxicity in two different hypofractionated 3D-conformal external beam radiotherapy
    schedules in localised muscle invasive bladder cancer
    V. Kouloulias, E. Mosa, M. Tolia, I. Kantzou, N. Koliarakis, K. Platoni, I. Georgakopoulos, A. Siatelis, G. Sarris,
    I. Beli, M. Chrisofos, N. Kelekis; pp 942-948 (Abstract, PDF)

    Neoadjuvant hormonal therapy in prostate cancer – impact of PSA level before radiotherapy
    M. Dolezel, K. Odrazka, J. Vanasek, M. Vaculikova, J. Vlkova-Sefrova, J. Jansa, Z. Macingova, M. Brodak, I.
    Hartmann, B. Melichar; pp 949-953 (Abstract, PDF)

    Preoperative Gleason score, percent of positive prostate biopsies and PSA in predicting biochemical recurrence
    after radical prostatectomy
    M. Acimovic, K. Dabic-Stankovic, T. Pejcic, Z. Dzamic, D. Rafailovic, J. Hadzi-Djokic; pp 954-960 (Abstract, PDF)

    Genetic polymorphisms of vitamin D receptor and the risk of prostate cancer: A meta-analysis
    Qingchuan Zhang, Yuxi Shan; pp 961-969 (Abstract, PDF)

    HEAD AND NECK CANCER

    Experience with intensity-modulated radiotherapy in the treatment of head and neck cancer
    J. Vanasek, K. Odrazka, L. Dusek, J. Jarkovsky, R. Michalek, V. Chrobok, M. Dolezel, I. Kolarova; pp 970-976 (Abstract, PDF)

    Determination of matrix metalloproteinase 9 (MMP-9) protein expression in laryngeal squamous cell
    carcinomas based on digital image analysis
    T.Ath. Papadas, S.S. Naxakis, N.S. Mastronikolis, T. Stathas, N.Ch. Karabekos, E. Tsiambas; pp 977-981 (Abstract, PDF)

    Combination of p16 levels and pre-radiotherapy factors predicts outcome in patients treated for oropharyngeal
    carcinoma
    V. Bar-Ad, ZX. Wang, B. Leiby, M. Tuluc; pp 982-988 (Abstract, PDF)

    COLORECTAL CANCER

    What is the significance of a microscopically positive resection margin in the curative-intent treatment of
    rectal adenocarcinoma? A retrospective study
    Z. Fekete, A. Muntean, A. Irimie, S. Hica, L. Resiga, N. Todor, V. Nagy; pp 989-995 (Abstract, PDF)

    HEMATOLOGICAL MALIGNANCIES

    Proteomic studies of multiple myeloma in RPMI8226 cell line treated with bendamustine
    Chenglong Sun, Juan Li, Jingli Gu, Junru Liu, Beihui Huang; pp 996-1005 (Abstract, PDF)

    CNS TUMORS

    CDC25B, Ki-67, and p53 expressions in reactive gliosis and astrocytomas
    D. Suren, O. Isiksacan Ozen; pp 1006-1011 (Abstract, PDF)

    CANCER PAIN

    Preclinical evidence for the antihyperalgesic activity of CDP-choline in oxaliplatin-induced neuropathic
    paın
    O. Kanat, D. Bagdas, H.Y. Ozboluk, M. S. Gurun; pp 1012-1018 (Abstract, PDF)

    CHILDHOOD CANCER

    The importance of the blood levels of homocysteine, folic acid and vitamin B12 in children with malignant
    diseases
    D. Aleksic, D. Djokic, I. Golubicic, V. Jakovljevic, D. Djuric; pp 1019-1025 (Abstract, PDF)

    LIVER CANCER

    Clinicopathological features and management of hepatic vascular tumors. A 20-year experience in a Greek
    University Hospital
    T. Theodosopoulos, D. Dellaportas, A. Tsangkas, N. Dafnios, V. Psychogiou, A. Yiallourou, G. Polymeneas, A.
    Kondi-Pafiti; pp 1026-1031 (Abstract, PDF)

    OSTEOSARCOMAS

    Histone deacetylase inhibitors suppress the growth of human osteosarcomas in vitro and in vivo
    Zhenkai Wu, Chao Ma, Zhi Shan, Yaping Ju, Siyu Li, Qinghua Zhao; pp 1032-1037 (Abstract, PDF)

    CANCER EPIDEMIOLOGY

    Cancer burden of breast and gynecological cancers in Bulgaria: epidemiology and clinical aspects
    G. Chakalova, N. Dimitrova, I. Gavrilov, Z. Valerianova; pp 1038-1044 (Abstract, PDF)

    QUALITY ASSURANCE IN RADIOTHERAPY

    Significance of using DICOM communication standard in quality assurance in radiation oncology – an
    institutional experience
    P. Tobias, D. Vrana, K. Cwiertka, D. Gremlica, P. Slampa; pp 1045-1047 (Abstract, PDF)

    ALTERNATIVE CANCER TREATMENTS

    The prevalence of usage of herbal medicines among cancer patients
    S. Tuna, O. Dizdar, M. Calis; pp 1048–1051 (Abstract, PDF)

    MISCELLANEOUS

    Can the epirubicin cardiotoxicity in cancer patients be prevented by angiotensin converting enzyme inhibitors?
    D. Radulescu, E. Buzdugan, T. E. Ciuleanu, N. Todor, L. Stoicescu; pp 1052-1057 (Abstract, PDF)

    Administration of gemcitabine and cisplatin in cancer patients with renal failure under hemodialysis
    Ping-Ying Chang, Ming-Shen Dai, Ching-Liang Ho, Nai-Shun Yao; pp 1058-1061 (Abstract, PDF)

    In vitro study on the effect of doxorubicin on the proliferation markers MCM3 and Ki-67
    S. Etemad-Moghadam, S. Fouladdel, E. Azizi, M. Alaeddini; pp 1062-1068 (Abstract, PDF)

    Construction and identification of the recombinant lentiviral expression vector targeting human Bax inhibitor-1 gene
    Hai-qing Luo, Wang-tao Zhong, Fu-mei Liu, Zhong-yi Cui, Ke-yuan Zhou, Xiang-yong Li; pp 1069-1073 (Abstract, PDF)

    Technetium-99m- Arg-Arg-Leu(g2) , a modified peptide probe targeted to neovascularization in molecular
    tumor imaging
    Xia Lu, Lingzhou Zhao, Tian Xue, Huabei Zhang; pp 1074-1081 (Abstract, PDF)

    SPECIAL ARTICLES

    An international survey of practice patterns and difficulties in cancer pain management in Southeastern
    Europe: A Turkish & Balkan Oncology Group common initiative
    Ajlan Atasoy, Gordana Bogdanovic, Archil Aladashvili, Zeljka Cvijetic, Mircea Dediu, Nada Cicmil-Saric,
    Armen Nersesyan, Athanasios Athanasiou, Nazim Serdar Turhal; pp 1082-1087 (Abstract, PDF)

    Increasing performance of a hospital-based cancer registry: Hacettepe University hospitals experience
    T. Kutluk, K. Mutlu Hayran, S. Kilickap, D. Yuce, I. Celik, M. Erman, S. Yalcin; pp 1088-1096 (Abstract, PDF)

    LETTERS TO THE EDITOR

    Possible role for furazolidone in the treatment of glioblastoma multiforme
    Petros N. Karamanakos; p 1097 (Abstract, PDF)

    Dissociated evolution of a multifocal primary CNS lymphoma
    C. Bagacean, M. Zdrenghea, C. Popescu, I. Quintin-Roue, J-C. Ianotto, J-R. Eveillard, C. Berthou, A. Tempescul; p 1098 (Abstract, PDF)

    Correlation of serum proteomics patterns of sCD200 (OΧ-2), sApo-2L (sTRAIL), vitamin-D and homocysteine
    to quantitative FDG-PET/CT findings in newly diagnosed non-small cell lung cancer
    A. Bisgnin, A. D. Yalcin, S. Gumuslu, B. Kargi, A. Kargi, B. Savas, L.G. Strauss; pp 1099-1100 (Abstract, PDF)

    HISTORY OF ONCOLOGY

    The eminent dermatologist Moriz Kaposi (1837-1902) and the first description of idiopathic multiple
    pigmented sarcoma of the skin
    M. Karamanou, C. Antoniou, A.J. Stratigos, Z. Saridaki, G. Androutsos; pp 1101-1105 (Abstract, PDF)

    Correction

    In vol.18 (1): 124-130,2013 issue (c-MYC and h-TERT co-expression in colon adenocarcinoma: a tissue microarray digitized image analysis) there was a mistake in the authors’ names sequence. The correct sequence is: Georgakopoulos G., Tsiambas E., Korkolopoulos P., Kavantzas N., Karameris A., Ragkos V., Rigopoulos, D.N.,Vilaras G. ,Athanasiou A.E., Tatsiou D., Patsouris E. The authors apologise for their mistake.

    Don't Miss
    Volume 27, 2024

    Two Cases of Pancreatic Metastases from Renal Cell Carcinoma and Review of the Literature

    April 17, 2025

    Dimosthenis Chrysikos1, Spiros Delis2, Charina Triantopoulou2, Evgenia Charitaki2, Nikos Kokoroskos2, Nikolaos Taprantzis1*, Amir Shihada1, Konstantinos…

    Exploration of Matrix Metalloproteinase-9 and Interleukin-8 in Breast Cancer Patients with No Lymph Node Involvement

    March 14, 2025

    Surgical Treatment of Right Atrial Metastasis of the Malignant Melanoma: A Case Report

    March 6, 2025

    Abdominal Aortic Aneurysm and Radiation Therapy

    October 28, 2024
    Our Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021

    Subscribe to Updates

    About Us
    About Us

    Journal of BUON (Print ISSN: 1107-0625, Electronic ISSN: 2241-6293) is an independent Open Access Journal, published by BAKIS Productions LTD, and appears exclusively on the internet. It is covered/indexed in Current Awareness in Biological Sciences (BIO-BASE), EMBASE/Excerpta Medica.
    We're accepting new manuscripts right now.

    Email Us: editorial_office@jbuon.com
    Contact: Available soon

    Editorial Picks

    MicroRNA signatures landscape in renal cell carcinoma – related epithelial to mesenchymal transition

    December 1, 2021

    Chromosomal instability landscape in uveal melanoma

    December 1, 2021

    Biomarkers and common oral cancers: Clinical trial studies

    December 1, 2021
    Get in Touch

    Editor-in-Chief
    Athanasios E. Athanasiou,
    Department of Medical Oncology,
    Metaxa Cancer Hospital, Botassi 51, 18537, Piraeus, Greece
    Editorial Office: editorial_office@jbuon.com

    Publishing support
    EManuscript Technologies
    # 9, First Floor, Vinnse Towers
    Wheeler Road Extension, St. Thomas Town, Bangalore 560 084, INDIA
    E: journals@emanuscript.in 
    W : www.emanuscript.in

     

    • Home
    • Author Guidelines
    • Site Map
    • Contact Us
    © 2025 JBUON Powered by EManuscript.

    Type above and press Enter to search. Press Esc to cancel.